These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8172205)

  • 1. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis.
    Clark WF; Parbtani A
    Am J Kidney Dis; 1994 May; 23(5):644-7. PubMed ID: 8172205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.
    Clark WF; Parbtani A; Huff MW; Reid B; Holub BJ; Falardeau P
    Kidney Int; 1989 Oct; 36(4):653-60. PubMed ID: 2811063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil in lupus nephritis: clinical findings and methodological implications.
    Clark WF; Parbtani A; Naylor CD; Levinton CM; Muirhead N; Spanner E; Huff MW; Philbrick DJ; Holub BJ
    Kidney Int; 1993 Jul; 44(1):75-86. PubMed ID: 8355469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of MRL/lpr lupus nephritis by dietary flaxseed.
    Hall AV; Parbtani A; Clark WF; Spanner E; Keeney M; Chin-Yee I; Philbrick DJ; Holub BJ
    Am J Kidney Dis; 1993 Aug; 22(2):326-32. PubMed ID: 8352261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flaxseed: a potential treatment for lupus nephritis.
    Clark WF; Parbtani A; Huff MW; Spanner E; de Salis H; Chin-Yee I; Philbrick DJ; Holub BJ
    Kidney Int; 1995 Aug; 48(2):475-80. PubMed ID: 7564115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of autoimmune disease by dietary n-3 fatty acids.
    Robinson DR; Xu LL; Tateno S; Guo M; Colvin RB
    J Lipid Res; 1993 Aug; 34(8):1435-44. PubMed ID: 8409774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flaxseed and flax oil diets in a rat-5/6 renal ablation model.
    Ingram AJ; Parbtani A; Clark WF; Spanner E; Huff MW; Philbrick DJ; Holub BJ
    Am J Kidney Dis; 1995 Feb; 25(2):320-9. PubMed ID: 7847360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus.
    Duffy EM; Meenagh GK; McMillan SA; Strain JJ; Hannigan BM; Bell AL
    J Rheumatol; 2004 Aug; 31(8):1551-6. PubMed ID: 15290734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus.
    Wright SA; O'Prey FM; McHenry MT; Leahey WJ; Devine AB; Duffy EM; Johnston DG; Finch MB; Bell AL; McVeigh GE
    Ann Rheum Dis; 2008 Jun; 67(6):841-8. PubMed ID: 17875549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary omega-3 lipids delay the onset and progression of autoimmune lupus nephritis by inhibiting transforming growth factor beta mRNA and protein expression.
    Chandrasekar B; Troyer DA; Venkatraman JT; Fernandes G
    J Autoimmun; 1995 Jun; 8(3):381-93. PubMed ID: 7575999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ω-3 polyunsaturated fatty acid alleviates systemic lupus erythematosus by suppressing autoimmunity in a murine model.
    Liu A; Li Z; Zeng J; Peng Y; Wang S; Bi X; Zhao Z; Zhou S; Zhao AZ; Mu Y; Li F
    Int Immunopharmacol; 2024 Jan; 126():111299. PubMed ID: 38043268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    J Diabetes Complications; 2017 Sep; 31(9):1394-1400. PubMed ID: 28716357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel treatment for lupus nephritis: lignan precursor derived from flax.
    Clark WF; Muir AD; Westcott ND; Parbtani A
    Lupus; 2000; 9(6):429-36. PubMed ID: 10981647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis.
    Chandrasekar B; Fernandes G
    Biochem Biophys Res Commun; 1994 Apr; 200(2):893-8. PubMed ID: 8179624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
    Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
    Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.